Cargando…
Novel Resistance Mechanisms to Osimertinib Analysed by Whole-Exome Sequencing in Non-Small Cell Lung Cancer
PURPOSE: Molecular-based targeted therapy has improved life expectancy for advanced non-small cell lung cancer (NSCLC). However, it does not have to be inevitable that patients receiving third-generation EGFR-TKIs become drug resistant. EGFR C797S and MET amplification are common mechanisms of osime...
Autores principales: | Wu, Zhen, Zhao, Wei, Yang, Zhen, Wang, Yue Ming, Dai, Yu, Chen, Liang-An |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920504/ https://www.ncbi.nlm.nih.gov/pubmed/33658860 http://dx.doi.org/10.2147/CMAR.S292342 |
Ejemplares similares
-
Discovering novel mechanisms of taxane resistance in human breast cancer by whole-exome sequencing
por: Wanifuchi-Endo, Yumi, et al.
Publicado: (2022) -
Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer
por: Leonetti, Alessandro, et al.
Publicado: (2019) -
Mechanisms of resistance to osimertinib
por: Lazzari, Chiara, et al.
Publicado: (2020) -
NCI-60 Whole Exome Sequencing and Pharmacological CellMiner Analyses
por: Reinhold, William C., et al.
Publicado: (2014) -
Tumor Mutational Burden and Genomic Alterations in Chinese Small Cell Lung Cancer Measured by Whole-Exome Sequencing
por: Su, Shan, et al.
Publicado: (2019)